Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zenith Goldline

This article was originally published in The Tan Sheet

Executive Summary

Trade journal print ads expected to break in January for a new line of standardized herbal extract softgels. The firm says the line is manufactured at its Miami facility under Rx good manufacturing practice standards, and a certificate of analysis is supplied for each batch. The softgels began shipping under the Goldline Naturals brand to independent pharmacies in early October; private label products, featuring clear bottles of colorful softgels, should reach store shelves in early 2000. The company will roll out a new $1.5 mil. ad campaign for its full line of Rx drugs, OTCs and herbals in 2000 and also is developing, in conjunction with the University of Florida, a pharmacists' continuing education course on herbals

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel